• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. DERMABOND PRINEO 42CM MSH 3.8ML ADHESIVE; CUTANEOUS TISSUE ADHESIVE WITH MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. DERMABOND PRINEO 42CM MSH 3.8ML ADHESIVE; CUTANEOUS TISSUE ADHESIVE WITH MESH Back to Search Results
Model Number CLR422US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypersensitivity/Allergic reaction (1907); Inflammation (1932); Pain (1994); Swelling (2091)
Event Date 01/01/2019
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).Attempts to obtain the following information has been performed but not received.If the further details are received at a later date a supplemental medwatch will be sent photo of reaction? procedure name? procedure date? date reaction noted? was there any other treatment provided (product removed; reoperation; reclosure; prescription steroids; antibiotics prescribed) in addition to steroids? if so, please clarify please indicate any medical or surgical interventions performed.Please describe how was the adhesive was applied.What prep was used prior to, during or after dermabond advanced use? was a dressing placed over the incision? if so, what type of cover dressing used? is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? is the patient hypersensitive to pressure sensitive adhesives? were any patch or sensitivity tests performed? what is the physicians opinion of the contributing factors to the reaction? what is the most current patient status? is the product lot available or representative sample (product from the same lot number) available for evaluation? patient demographics: initials / id; age or date of birth; bmi; gender.Patient pre-existing medical conditions (ie.Allergies, history of reactions) was prineo/demabond or skin adhesive used on the patient in a previous surgery or wound closure? to date the device has not been received.If the further details are received at a later date a supplemental medwatch will be sent.
 
Event Description
It was reported a patient underwent an unknown plastic surgery procedure on an unknown date and topical skin adhesive was used.Patient experienced severe reaction with swelling, redness under and around adhesive and pain.Steroids administered to treat additional information was requested.
 
Manufacturer Narrative
Product complaint # (b)(4).Attempts to obtain the following information has been performed and the following was received.If the further details are received at a later date a supplemental medwatch will be sent unfortunately i have received no further information and i doubt i will be able to gather any more intel for you.I will let you know if anything changes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DERMABOND PRINEO 42CM MSH 3.8ML ADHESIVE
Type of Device
CUTANEOUS TISSUE ADHESIVE WITH MESH
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
MDR Report Key9952843
MDR Text Key187411798
Report Number2210968-2020-02959
Device Sequence Number1
Product Code OMD
UDI-Device Identifier10705031240421
UDI-Public10705031240421
Combination Product (y/n)N
PMA/PMN Number
K163645
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 03/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/13/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCLR422US
Device Catalogue NumberCLR422US
Was Device Available for Evaluation? No
Date Manufacturer Received04/15/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-